EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Comparative Analysis of Intravenous Immunoglobulins (IVIg) vs Plasmapheresis (PLEX) in the Management of Myasthenic Crisis

Ahmad Zain, Muhammad Shariq Akram, Fatima Ashfaq, Armghan Ans, Hasaan H Ans

Cureus · 07.09.2024

DOI: 10.7759/cureus.68895 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 07.09.2024. Verfasst von Ahmad Zain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Services Hospital Lahore, Lahore, PAK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myasthenia gravis (MG) is an autoimmune disorder affecting postsynaptic membranes in neuromuscular junctions, presenting as fatigable muscle weakness. Myasthenic crisis is a life-threatening complication characterized by severe respiratory insufficiency necessitating invasive or noninvasive ventilation. Two rapid therapies used to manage myasthenic crises are intravenous immunoglobulins (IVIg) and plasmapheresis (PLEX). Their comparative effectiveness remains equivocal. Our article examines evidence from several clinical trials and observational studies, in order to determine the superiority of one treatment over the other. Multiple factors can complicate the choices between two treatments. We concluded that the choice between PLEX and IVIg is multifaceted, guided by individual patient characteristics, institutional resources, and clinician preference. While PLEX can be considered as first-line for rapid clinical outcomes, it is hard to pick one treatment over the other, and careful consideration of comorbidities and resource availability is crucial. Our article highlights the need for further research to establish definitive guidelines and enhance patient outcomes in myasthenic crisis patients.

Schlagwörter

Stichwörter der Autor:innen

intravenous immunoglobulin (ivig)myasthenia gravis (mg)myasthenia gravis crisismyasthenia gravis exacerbationplasmapharesis

Autor:innen und Institutionen

  • Internal Medicine, Services Hospital Lahore, Lahore, PAK.
  • Internal Medicine, King Edward Medical University (KEMU), Lahore, PAK.
  • Radiology, Stanford University, Palo Alto, USA.
  • Internal Medicine, Services Institute of Medical Sciences, Lahore, PAK.
  • Neurology, Medical College of Wisconsin, Milwaukee, USA.
  • Vascular Neurology, University of Pittsburgh Medical Center, Pittsburgh, USA.

Zitieren

APA

Zain, A., Akram, M. S., Ashfaq, F., Ans, A., & Ans, H. H. (2024). Comparative Analysis of Intravenous Immunoglobulins (IVIg) vs Plasmapheresis (PLEX) in the Management of Myasthenic Crisis. Cureus. https://doi.org/10.7759/cureus.68895

Vancouver

Zain A, Akram MS, Ashfaq F, Ans A, Ans HH. Comparative Analysis of Intravenous Immunoglobulins (IVIg) vs Plasmapheresis (PLEX) in the Management of Myasthenic Crisis. Cureus. 2024. doi:10.7759/cureus.68895

BibTeX
@article{Zain2024,
  author = {Zain, Ahmad and Akram, Muhammad Shariq and Ashfaq, Fatima and Ans, Armghan and Ans, Hasaan H},
  title = {Comparative Analysis of Intravenous Immunoglobulins (IVIg) vs Plasmapheresis (PLEX) in the Management of Myasthenic Crisis},
  journal = {Cureus},
  year = {2024},
  doi = {10.7759/cureus.68895}
}
Kostenlos starten →